Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 pandemic: An overview
Cecilia Acuti Martellucci, Maria Elena Flacco, Rosaria Cappadona, et al.
Advances in Biological Regulation (2020) Vol. 77, pp. 100736-100736
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India – a community based survey
Kenneth Grace Mascarenhas Danabal, Shiva Shankar Magesh, S. Saravanan, et al.
BMC Health Services Research (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 151
COVID-19 associated myocarditis: A systematic review
William Haussner, Antonio P. DeRosa, Danielle Haussner, et al.
The American Journal of Emergency Medicine (2021) Vol. 51, pp. 150-155
Open Access | Times Cited: 67
Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province
Maria Elena Flacco, Graziella Soldato, Cecilia Acuti Martellucci, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 628-628
Open Access | Times Cited: 49
Changes in physical activity levels, eating habits and psychological well-being during the Italian COVID-19 pandemic lockdown: Impact of socio-demographic factors on the Florentine academic population
Gabriele Mascherini, Dolores Catelan, Domenico E. Pellegrini‐Giampietro, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0252395-e0252395
Open Access | Times Cited: 44
COVID‐19 metabolism: Mechanisms and therapeutic targets
Tianshi Wang, Ying Cao, Haiyan Zhang, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 33
Effectiveness of COVID-19 Vaccines in the General Population of an Italian Region before and during the Omicron Wave
Cecilia Acuti Martellucci, Maria Elena Flacco, Graziella Soldato, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 662-662
Open Access | Times Cited: 32
Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses
Linda Sukmarini
Molecules (2022) Vol. 27, Iss. 9, pp. 2619-2619
Open Access | Times Cited: 31
Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development
Julie Bigay, Roger Le Grand, Frédéric Martinon, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 29
Understanding the time-driven shifts of vaccine effectiveness against any and severe COVID-19 before and after the surge of Omicron variants within 2.5 years of vaccination: A meta-regression
Marek Petráš, D Janovská, Danuše Lomozová, et al.
International Journal of Infectious Diseases (2024) Vol. 142, pp. 106986-106986
Open Access | Times Cited: 6
Cost‐effectiveness of plasmapheresis and hemoperfusion in COVID‐19 survivors: A six‐month follow‐up analysis after hospital discharge
Soroush Dianaty, Farshid Gholami, Hamid Reza Gholamrezaie, et al.
Therapeutic Apheresis and Dialysis (2025)
Closed Access
The Effectiveness of Four Quadrivalent, Inactivated Influenza Vaccines Administered Alone or in Combination with Pneumococcal and/or SARS-CoV-2 Vaccines: A Population-Wide Cohort Study
Cecilia Acuti Martellucci, Annalisa Rosso, Enrico Zauli, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 309-309
Open Access
Risk communication in the containment of the COVID-19 pandemic: challenges and promising approaches
Julika Loss, Evgeniya Boklage, Susanne Jordan, et al.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2021) Vol. 64, Iss. 3, pp. 294-303
Open Access | Times Cited: 39
Prospective Role of Peptide-Based Antiviral Therapy Against the Main Protease of SARS-CoV-2
Shafi Mahmud, Gobindo Kumar Paul, Suvro Biswas, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 36
Exploring the potential of novel phenolic compounds as potential therapeutic candidates against SARS-CoV-2, using quantum chemistry, molecular docking and dynamic studies
Maimoona Zia, Shabbir Muhammad, Shafiq‐ur‐Rehman, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 43, pp. 128079-128079
Open Access | Times Cited: 34
Omicron BA.2.75 Sublineage (Centaurus) Follows the Expectations of the Evolution Theory: Less Negative Gibbs Energy of Biosynthesis Indicates Decreased Pathogenicity
Marko Popovic
Microbiology Research (2022) Vol. 13, Iss. 4, pp. 937-952
Open Access | Times Cited: 25
Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and Delta variant infections in China
Qinggang Li, Xiaorui Liu, Lei Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 22
Quinones as Promising Compounds against Respiratory Viruses: A Review
Iván Chan‐Zapata, Rocı́o Borges-Argáez, Guadalupe Ayora‐Talavera
Molecules (2023) Vol. 28, Iss. 4, pp. 1981-1981
Open Access | Times Cited: 13
The Antiviral Activity of GcMAF in the Treatment of Experimental Animals Infected with SARS-CoV-2
Anastasia S. Proskurina, О. С. Таранов, С. С. Кирикович, et al.
COVID (2025) Vol. 5, Iss. 3, pp. 36-36
Open Access
COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up
Annalisa Rosso, Maria Elena Flacco, Graziella Soldato, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1325-1325
Open Access | Times Cited: 10
Efficiency of antiviral treatment in COVID‑19
Nicoleta Negruț, Adriana Codrean, Ioana Hodisan, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 6
Open Access | Times Cited: 24
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies
Guo Du, Huaichuan Duan, Yan Cheng, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 18
Inhaled CO2 Concentration While Wearing Face Masks: A Pilot Study Using Capnography
Cecilia Acuti Martellucci, Maria Elena Flacco, Mosè Martellucci, et al.
Environmental Health Insights (2022) Vol. 16
Open Access | Times Cited: 17
COVID-19 Vaccination Did Not Increase the Risk of Potentially Related Serious Adverse Events: 18-Month Cohort Study in an Italian Province
Maria Elena Flacco, Cecilia Acuti Martellucci, Graziella Soldato, et al.
Vaccines (2022) Vol. 11, Iss. 1, pp. 31-31
Open Access | Times Cited: 17
Function and Cryo-EM structures of broadly potent bispecific antibodies against multiple SARS-CoV-2 Omicron sublineages
Ping Ren, Yingxia Hu, Lei Peng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Children’s SARS-CoV-2 Infection and Their Vaccination
Sneh Lata Gupta, Rohit Tyagi, Atika Dhar, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 418-418
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top